169 Some evidence suggests omega-3 fatty acids may lower the risk of anovulation, increase ovarian reserve, and improve oocyte quality and embryo development
Reconstructing and comparing signal transduction networks from single-cell protein quantification data
While this study was not a head-to-head clinical trial comparison, it may be relevant that at week 12 of a weekly dosing regimen, some studies suggest that participants treated with semaglutide (Wegovy, Novo Nordisk) had an approximately 6% decrease from baseline in body weight, whereas those treated with tirzepatide (Zepbound, Eli Lilly) had an approximately 8% decrease from baseline in body weight at the same time period, Bays said
Brown, for example, says she hasnt noticed an increase in GI problems when patients take both medicines, but it is theoretically possible. Side effects often improve over time as your body adjusts, but combining the two could make it harder to tolerate one or both